Barrick Gold Corp
Change company Symbol lookup
Select an option...
GOLD Barrick Gold Corp
NFLX Netflix Inc
CDTX Cidara Therapeutics Inc
XBTAX BlackRock Long Term Municipal Advantage Trust
PBYA Probility Media Corp
RA Brookfield Real Assets Income Fund Inc.
PAA Plains All American Pipeline LP
GOOGL Alphabet Inc

Materials : Metals & Mining | Large Cap Growth
Based in Canada
Company profile

Barrick Gold Corp is a gold mining company. The Company is principally engaged in the production and sale of gold and copper, as well as related activities, such as exploration and mine development. The Company's segments include Barrick Nevada, Golden Sunlight, Hemlo, Jabal Sayid, Lagunas Norte, Lumwana, Porgera, Pueblo Viejo, Turquoise Ridge, Veladero and Zaldvar. Pueblo Viejo, Lagunas Norte, Veladero and Turquoise Ridge are its individual gold mines. The Company, through its subsidiary Acacia, owns gold mines and exploration properties in Africa. Its Porgera is a gold mine. Zaldivar and Lumwana are copper mines. The Pascua-Lama project is located on the border between Chile and Argentina. The Company owns a number of producing gold mines, which are located in Canada, the United States, Peru, Argentina, Australia and the Dominican Republic.

Closing Price
Day's Change
-0.54 (-2.01%)
B/A Size
Day's High
Day's Low
(Below Average)

10-day average volume:

Global Next-Generation Biomanufacturing Market 2019-2029, Featuring Company Analysis of Players Danaher, Merck KGaA and Eppendorf AG

3:13 am ET April 7, 2020 (Globe Newswire) Print

The "Global Next-Generation Biomanufacturing Market: Focus on Workflow, Product Type, Medical Applications, End Users, 5 Regional Data, 19 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to's offering.

The global next-generation biomanufacturing market was valued at $14.80 billion in 2018. With increasing commercialization of biopharmaceuticals and the addition of more products in the development pipeline, biopharmaceutical companies are looking forward to adopting novel biomanufacturing strategies with an increased focus on balancing innovation in process design, performance, and efficiency with speed and cost. The need for advanced biomanufacturing practices in order to meet the demand of the growing patient population has paved the way for the development of next-generation biomanufacturing products.

Next-generation biomanufacturing products are designed to provide seamless services that are superior in terms of both quality and efficiency as compared to first-generation products. Increased funding from private investors and the government for the development of next-generation biomanufacturing facilities promoting rapid technological advancement in biomanufacturing products is one of the most prominent factors driving the growth of the next-generation biomanufacturing market. One of the major trends of the next-generation biomanufacturing market is the shifting focus toward the adoption of single-use products, such as single-use bioreactors and single-use biocontainers. This is mainly attributed to the huge number of benefits associated with single-use products, with regard to cost savings, reduced risk of product contamination, and increased flexibility in multi-product facilities. With more companies entering the next-generation biomanufacturing market through product innovations, several novel next-generation biomanufacturing products are expected to come up, actively driving the growth of the market in the upcoming years.

This report provides an in-depth study of the global next-generation biomanufacturing market, including a thorough analysis of the types of products. The study also presents a detailed analysis of the market dynamics and an estimation of the market size over the forecast period 2019-2029. The scope of this report is focused on the different products, workflow, application areas, end users associated with the global next-generation biomanufacturing market, as well as the country-wise analysis.

Key Questions Answered in this Report:

-- What is the importance of biomanufacturing in the medical field?

-- What are the key trends of the global next-generation biomanufacturing market? How is the market evolving and what is its future scope?

-- What are the major drivers, challenges, and opportunities of the global next-generation biomanufacturing market?

-- What are the key developmental strategies implemented by the key players of the global next-generation biomanufacturing to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?

-- What is the regulatory scenario of the global next-generation biomanufacturing market?

-- What are the different next-generation biomanufacturing products used in the medical field? Which product type dominated the market in 2018 and why? Which product type is expected to witness the highest growth rate and to dominate in the market in 2029?

-- What are the different medical application areas of the global next-generation biomanufacturing market?

-- What are the different end users associated with next-generation biomanufacturing? What was the contribution of each user type in the global next-generation biomanufacturing market in 2018 and what is it expected to be in 2029?

-- Which region is expected to contribute the highest sales in the global next-generation biomanufacturing market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different next-generation biomanufacturing products?

-- What are the key players of the global next-generation biomanufacturing market and what is their role in the market?

Key Topics Covered:

Executive Summary

1 Product Definition

2 Scope of the Work

3 Research Methodology

4 Global Next-Generation Biomanufacturing Market Overview

5 Industry Insights

6 Competitive Landscape

7 Global Next-Generation Biomanufacturing Market (by Workflow and Product)

8 Global Next-Generation Biomanufacturing Market (by Medical Application)

9 Global Next-Generation Biomanufacturing Market (by End User)

10 Global Next-Generation Biomanufacturing Market (by Region)

11 Company Profiles

-- Applikon Biotechnology BV

-- bbi-biotech GmbH

-- Danaher Corporation

-- Eppendorf AG

-- Esco Group of Companies

-- GEA Group Aktiengesellschaft

-- Meissner Filtration Products, Inc.

-- Merck KGaA

-- PBS Biotech, Inc.

-- Pierre Gurin

-- Sartorius AG

-- Shanghai Bailun Biotechnology Co. Ltd.

-- Solaris Biotechnology Srl.

-- Thermo Fisher Scientific Inc.

-- ZETA GmbH

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.